Chapter 8
Eryptosis Assay and Flow Cytometry Analysis Previously described eryptosis inducers were selected for this study based on their use (or potential use) in the clinic, their known targets and/or their previously described antimalarial activity ( Table 1 ): amiodarone HCl (Selleck Chem, #S1979), apigenin (Selleck Chem, #S2262), BAY 43-9006 (AdipoGen Life Sciences, #AG-CR1-0025), benzethonium chloride (Selleck Chem, #S4162), cordycepin (Cayman Chemicals, #14426), ionomycin (ThermoFisher, #I24222) and oridonin (Selleck Chem, #S2335)
Research areas where laboratories buy BPC-157 for in vitro and preclinical work include gastric and intestinal mucosal-injury models, tendon and ligament fibroblast cultures examining outgrowth and collagen organization, endothelial angiogenesis assays with VEGF/eNOS readouts, and central and peripheral nervous-system injury models
Finally, fundamental scientific hurdles persist, including managing immunogenicity, overcoming tumor antigen heterogeneity, and ensuring linker stability to prevent off-target toxicity